Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria

Recent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK inhibitors unless there is no other alternative.
Medscape Medical News

source https://www.medscape.com/viewarticle/most-patients-rheumatoid-arthritis-meet-european-medicines-2024a10008kq?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost